Trademark Search in Canada

EMPRESS

View On IC.GC.CA

REGISTERED

on 14 Jun 2023

Last Applicant/ Owned by

Empress Therapeutics, Inc.

55 Cambridge Parkway, Suite 800ECambridge MA 02142

Serial Number

2089004 filed on 18^th Dec 2020

Registration Number

TMA1184931 registered on 14^th Jun 2023

Registration expiry Date

18^th Dec 2030

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

M5H3Y2

EMPRESS

Trademark usage description

pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrino Read More

Classification Information

Class [005]
Pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, namely, diabetes, obesity, insulin resistance, metabolic syndrome, gout, hypoglycaemia, hyperthyroidism, and hypothyroidism, neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders and neurodegenerative diseases and disorders

Classification kind code

Mark Details

Serial Number

2089004

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 4^th Jul 2022	Search Recorded
Submitted for opposition 20 on 4^th Jul 2022	Examiner's First Report
Submitted for opposition 223 on 4^th Jul 2022	Total Provisional Refusal
Submitted for opposition 256 on 4^th Jan 2022	Notification of Possible Opposition Sent
Submitted for opposition 48 on 1^st Jun 2021	Agent Changed
Submitted for opposition 257 on 4^th Mar 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 3^rd Mar 2021	Created
Submitted for opposition 31 on 3^rd Mar 2021	Formalized
Submitted for opposition 30 on 18^th Dec 2020	Filed
Submitted for opposition 228 on 18^th Dec 2020	International Registration